Forsvarsudvalget 2016-17
FOU Alm.del Bilag 29
Offentligt
1703588_0001.png
S. R. Noble-Letort, PhD Chairman
Nordic Integra;ve Medicine
www.nordicintegra;vemedicine.com
Danish Parliament
Defense Commi1ee
Deputa4on
8 December 2016
12/14/16 16:43
© Shelley Noble-Letort, PhD
director@nordicintegra;vemedicine.com
+45 2116 3939
1
FOU, Alm.del - 2016-17 - Bilag 29: Præsentation fra Nordic Integrative Medicines (NIM) foretræde 8/12-16 om en integreret sundhedspolitik, herunder for forsvarets personel
1703588_0002.png
Nordic Integrative Medicine
12/14/16 16:43
© Shelley Noble-Letort, PhD
director@nordicintegra;vemedicine.com
+45 2116 3939
2
FOU, Alm.del - 2016-17 - Bilag 29: Præsentation fra Nordic Integrative Medicines (NIM) foretræde 8/12-16 om en integreret sundhedspolitik, herunder for forsvarets personel
1703588_0003.png
What is Integra;ve Medicine?
12/14/16 16:43
© Shelley Noble-Letort, PhD
director@nordicintegra;vemedicine.com
+45 2116 3939
3
FOU, Alm.del - 2016-17 - Bilag 29: Præsentation fra Nordic Integrative Medicines (NIM) foretræde 8/12-16 om en integreret sundhedspolitik, herunder for forsvarets personel
1703588_0004.png
Integra;ve Medicine (IM) emphasizes integrated pa;ent care
that empowers the pa;ent by addressing the biophysical,
emo;onal, mental, social, existen;al and environmental
influences that affect a person’s health and coordinates care
with the selected support of a team of integra;ve
prac;;oners who develop a personalized health plan, which
supports the renewal of health and preven;on of disease.
12/14/16 16:43
© Shelley Noble-Letort, PhD
director@nordicintegra;vemedicine.com
+45 2116 3939
4
FOU, Alm.del - 2016-17 - Bilag 29: Præsentation fra Nordic Integrative Medicines (NIM) foretræde 8/12-16 om en integreret sundhedspolitik, herunder for forsvarets personel
1703588_0005.png
PATIENT-CENTERED
GENETICS IS NOT DESTINY
COMPASSIONATE CARE
LIFESTYLE MODIFICATION
PREVENTION & WELLNESS
NEW PARADIGM RESEARCH
12/14/16 16:43
© Shelley Noble-Letort, PhD
director@nordicintegra;vemedicine.com
+45 2116 3939
5
FOU, Alm.del - 2016-17 - Bilag 29: Præsentation fra Nordic Integrative Medicines (NIM) foretræde 8/12-16 om en integreret sundhedspolitik, herunder for forsvarets personel
1703588_0006.png
12/14/16 16:43
© Shelley Noble-Letort, PhD
director@nordicintegra;vemedicine.com
+45 2116 3939
6
FOU, Alm.del - 2016-17 - Bilag 29: Præsentation fra Nordic Integrative Medicines (NIM) foretræde 8/12-16 om en integreret sundhedspolitik, herunder for forsvarets personel
1703588_0007.png
NIM Center for
Integra;ve Health and Preven;on
Moving Healthcare into Sustainability
HIGH TOUCH
Compassionate,
Pa4ent-Empowered
Team-Integrated Healthcare
Cost-Effec;ve for Chronic Disease
Management and Preven;on
Time to Talk with
Team of Medical and
Complementary Prac44oners
HIGH TECH
Scien;fic Evidence-Based
Complementary Therapies and
Medicine working with
Conven;onal Medicine and
Innova;ve Biotech, Neuroscience
and Gene;c Risk Research
7
12/14/16 16:43
© Shelley Noble-Letort, PhD
director@nordicintegra;vemedicine.com
+45 2116 3939
FOU, Alm.del - 2016-17 - Bilag 29: Præsentation fra Nordic Integrative Medicines (NIM) foretræde 8/12-16 om en integreret sundhedspolitik, herunder for forsvarets personel
1703588_0008.png
12/14/16 16:43
© Shelley Noble-Letort, PhD
director@nordicintegra;vemedicine.com
+45 2116 3939
8
FOU, Alm.del - 2016-17 - Bilag 29: Præsentation fra Nordic Integrative Medicines (NIM) foretræde 8/12-16 om en integreret sundhedspolitik, herunder for forsvarets personel
1703588_0009.png
12/14/16 16:43
© Shelley Noble-Letort, PhD
director@nordicintegra;vemedicine.com
+45 2116 3939
9
FOU, Alm.del - 2016-17 - Bilag 29: Præsentation fra Nordic Integrative Medicines (NIM) foretræde 8/12-16 om en integreret sundhedspolitik, herunder for forsvarets personel
1703588_0010.png
Challenges in Health Care Delivery
Unfortunately,
access
to health
care services is severely
limited:
▪ 
Many lack access to
basic services
▪ 
Poor access leads to
higher mortality from
treatable diseases
Quality
is an enduring
challenge
▪ 
Access
Quality
Basic standards of
medical care a
challenge in many
developing
countries
Financial
Sustainability &
Cost
The
cost
of delivering health care is unsustainable
▪ 
▪ 
Unsustainable for countries with national healthcare coverage
Cost of care is catastrophic for families in countries without
strong insurance
coverage
12/14/16 16:43
© Shelley Noble-Letort, PhD
director@nordicintegra;vemedicine.com
+45 2116 3939
10
FOU, Alm.del - 2016-17 - Bilag 29: Præsentation fra Nordic Integrative Medicines (NIM) foretræde 8/12-16 om en integreret sundhedspolitik, herunder for forsvarets personel
1703588_0011.png
Epidemiological Disease Burden on Danish Society
(a) 800,000 patients; (b) 29,000 patients; (c) 4,700 patients; (d) 42,000 patients; (e) 1,900 patients; (f) 5.5 million sick-days; (g)
DKK 2.6 Bn
12/14/16 16:43
© Shelley Noble-Letort, PhD
director@nordicintegra;vemedicine.com
+45 2116 3939
11
FOU, Alm.del - 2016-17 - Bilag 29: Præsentation fra Nordic Integrative Medicines (NIM) foretræde 8/12-16 om en integreret sundhedspolitik, herunder for forsvarets personel
1703588_0012.png
Need for Earlier Intervention
Development of Disease
Baseline
Risk
Disease Burden
Earliest
Molecular
Detection
Earliest
Clinical
Detection
Typical
Current
Intervention
Initiating
Events
Personalized Medicine Tools
• 
Quantify Baseline
Risk
• 
• 
• 
Monitor Progression
Refine Risk Prediction
Define Disease
• 
• 
Monitor
Personalize Therapy
Personalized Health
Planning
12/14/16 16:43
Slide modified from Ralph Snyderman
© Shelley Noble-Letort, PhD
director@nordicintegra;vemedicine.com
+45 2116 3939
1/reversibility
12
Cost
 FOU, Alm.del - 2016-17 - Bilag 29: Præsentation fra Nordic Integrative Medicines (NIM) foretræde 8/12-16 om en integreret sundhedspolitik, herunder for forsvarets personel
1703588_0013.png
IM Clinical Success
12/14/16 16:43
© Shelley Noble-Letort, PhD
director@nordicintegra;vemedicine.com
+45 2116 3939
13
FOU, Alm.del - 2016-17 - Bilag 29: Præsentation fra Nordic Integrative Medicines (NIM) foretræde 8/12-16 om en integreret sundhedspolitik, herunder for forsvarets personel
1703588_0014.png
IM Therapies Applied
12/14/16 16:43
© Shelley Noble-Letort, PhD
director@nordicintegra;vemedicine.com
+45 2116 3939
14
FOU, Alm.del - 2016-17 - Bilag 29: Præsentation fra Nordic Integrative Medicines (NIM) foretræde 8/12-16 om en integreret sundhedspolitik, herunder for forsvarets personel
1703588_0015.png
IM Prac;;oners Employeed
12/14/16 16:43
© Shelley Noble-Letort, PhD
director@nordicintegra;vemedicine.com
+45 2116 3939
15
FOU, Alm.del - 2016-17 - Bilag 29: Præsentation fra Nordic Integrative Medicines (NIM) foretræde 8/12-16 om en integreret sundhedspolitik, herunder for forsvarets personel
1703588_0016.png
NATO Science and Technology Organization
13/05/13 21:00
NATO Science and Technology Organisa4on (STO)
Human Factors and Medicine (HFM) Panel
Submarine Officers from
the Italian Naval
Academy in Livorno Visit
the CMRE
Search
Home
Organization
CSO (Former RTA)
CMRE (Former NURC)
Publications
More
OUR ORGANIZATION
NATO Task Force 195:
Integra4ve Medicine Interven4ons for Military Personnel
NATO-STO-RTG-TR-HFM-195 (2010-2014)
The long-standing collaboration
between the two establishments
leads to a series of lectures on
cutting-edge scientific innovation in
the field of antisubmarine warfare.
12 April 2013
Read the full story
COUNTRY COORDINATION
USA
NATO Chief Scientist welcomes the new Organization
COUNTRIES PARTICIPANTS
FRANCE
GERMANY
HUNGARY
ITALY
NETHERLANDS
USA
Dear All,
We would like to welcome you to your new home base, the Science and
Technology Organisation (STO).
On 1 July the STO stood up, with the new NATO Chief Scientist providing
unified S&T leadership; merging the forces, the skills and the expertise of the
NATO Undersea Research Centre and the Research and Technology
Organisation; and creating the Office of the NATO Chief Scientist in NATO
Headquarters.
We also would like to thank you for all the hard work you have performed,
getting the S&T community to where it is today: known for excellence and
better positioned than ever to make a difference and to contribute to the
Security and Defence of the Alliance.
The Science and
Technology
Organization (STO) is a
NATO subsidiary body
having the same legal
status than the NATO
itself, and created
within the framework
of the North Atlantic Treaty signed in Washington
in 1949. It has been established with a view to
meeting to the best advantage the collective
needs of NATO, NATO Nations and partner
Nations in the fields of Science and Technology.
The STO is operated under the authority of the
North Atlantic Council which has delegated the
operations of the STO to a Board of Directors
(the S&T Board – STB) comprising the NATO
Nations S&T managers. The STB is chaired by the
NATO Chief Scientist who is a high level
recognized S&T leader of a NATO Nation, being
permanently assigned to the NATO headquarters
in Brussels and also serving as the senior scientific
advisor to the NATO leadership.
More...
12/14/16 16:43
© Shelley Noble-Letort, PhD
STO Facebook
director@nordicintegra;vemedicine.com
Page
CMRE Facebook Page
+45 2116 3939
CSO Youtube Channel
SOCIAL MEDIA
16
FOU, Alm.del - 2016-17 - Bilag 29: Præsentation fra Nordic Integrative Medicines (NIM) foretræde 8/12-16 om en integreret sundhedspolitik, herunder for forsvarets personel
1703588_0017.png
What is the NATO Science and Technology Organisa4on (STO) ?
The NATO Science and Technology Organisa4on (STO) promotes
and conducts co-opera;ve scien;fic research and exchange of
technical informa;on amongst 28 NATO na;ons and 38 NATO
partners.
The largest such collabora;ve body in the world, the STO
encompasses over 3000 scien;sts and engineers addressing the
complete scope of defence technologies and opera;onal
domains.
This effort is supported by an execu;ve agency, the Research and
Technology Agency (RTA), that facilitates the collabora;on by
organising a wide range of studies, workshops, symposia, and
other forums in which researchers can meet and exchange
knowledge.
12/14/16 16:43
© Shelley Noble-Letort, PhD
director@nordicintegra;vemedicine.com
+45 2116 3939
17
FOU, Alm.del - 2016-17 - Bilag 29: Præsentation fra Nordic Integrative Medicines (NIM) foretræde 8/12-16 om en integreret sundhedspolitik, herunder for forsvarets personel
1703588_0018.png
What is the Mission of the
HUMAN FACTORS AND MEDICINE (HFM) Panel ?
The mission of the Human Factors and Medicine Panel
(HFM) is to provide the science and technology base for
op;mising health, human protec;on, well being and
performance of the human in opera;onal environments
with considera;on of affordability.
This involves understanding and ensuring the physical,
physiological, psychological and cogni;ve compa;bility
among military personnel, technological systems, missions,
and environments.
This is accomplished by exchange of informa;on,
collabora;ve experiments and shared field trials.
© Shelley Noble-Letort, PhD
director@nordicintegra;vemedicine.com
+45 2116 3939
12/14/16 16:43
18
FOU, Alm.del - 2016-17 - Bilag 29: Præsentation fra Nordic Integrative Medicines (NIM) foretræde 8/12-16 om en integreret sundhedspolitik, herunder for forsvarets personel
1703588_0019.png
Home
Organization
CSO (Former RTA)
CMRE (Former NURC)
Publications
More
What are the Driving Forces and Objec4ves of the
Submarine Officers from
NATO Task Force 195:
the Italian Naval
Academy in Livorno Visit
Integra4ve Medicine Interven4ons for Military Personnel
OUR ORGANIZATION
the CMRE
NATO-STO-RTG-TR-HFM-195 (2010-2014)
Search
More than 50% of the military popula;on, including dependants, have used CAM
12 April 2013
interven;ons in recent years, and 66%
Read the
ac;ve duty personnel use dietary
of
full story
supplements.
Objec4ves
• 
Iden;fy
NATO Chief
evaluate countries’ data on the use of CAM among military
and
Scientist welcomes the new Organization
personnel.
Dear All,
We would like to welcome you to your new home base, the Science and
• 
Determine how personnel in each country access CAM interven;ons (directly or
Technology Organisation (STO).
On 1 July the STO stood up, with the new NATO Chief Scientist
by prescrip;on), and with what frequency.
providing
unified S&T leadership; merging the forces, the skills and the expertise of the
• 
Assess how important,
Research Centre and the Research and Technology
NATO Undersea
accepted, and regulated is the use of CAM in the
Organisation; and creating the Office of the NATO Chief Scientist in NATO
therapeu;c arsenal
Headquarters.
would
for all
hard
have performed,
• 
Share all available
We alsothe S&Tlike to thank youwhere itthe today:work youfor excellence and
and effects of any type of CAM
research on the indica;ons
getting
community to
is
known
better positioned than ever to make a difference and to contribute to the
interven;ons, as well as any possible adverse effects on military readiness.
Security and Defence of the Alliance.
The long-standing collaboration
between the two establishments
leads to a series of lectures on
cutting-edge scientific innovation in
the field of antisubmarine warfare.
The Science and
Technology
Organization (STO) is a
NATO subsidiary body
having the same legal
status than the NATO
itself, and created
within the framework
of the North Atlantic Treaty signed in Washington
in 1949. It has been established with a view to
meeting to the best advantage the collective
needs of NATO, NATO Nations and partner
Nations in the fields of Science and Technology.
The STO is operated under the authority of the
North Atlantic Council which has delegated the
operations of the STO to a Board of Directors
(the S&T Board – STB) comprising the NATO
Nations S&T managers. The STB is chaired by the
NATO Chief Scientist who is a high level
recognized S&T leader of a NATO Nation, being
permanently assigned to the NATO headquarters
in Brussels and also serving as the senior scientific
advisor to the NATO leadership.
More...
12/14/16 16:43
© Shelley Noble-Letort, PhD
STO Facebook
director@nordicintegra;vemedicine.com
Page
CMRE Facebook Page
+45 2116 3939
CSO Youtube Channel
SOCIAL MEDIA
19
FOU, Alm.del - 2016-17 - Bilag 29: Præsentation fra Nordic Integrative Medicines (NIM) foretræde 8/12-16 om en integreret sundhedspolitik, herunder for forsvarets personel
1703588_0020.png
World Economic Forum
Innova;ve Financing: Public-Private Coopera;on and
Noncommunicable Diseases (NCD)
12/14/16 16:59
© Shelley Noble-Letort, PhD
director@nordicintegra;vemedicine.com
+45 2116 3939
20
FOU, Alm.del - 2016-17 - Bilag 29: Præsentation fra Nordic Integrative Medicines (NIM) foretræde 8/12-16 om en integreret sundhedspolitik, herunder for forsvarets personel
1703588_0021.png
12/14/16 17:00
© Shelley Noble-Letort, PhD
director@nordicintegra;vemedicine.com
+45 2116 3939
21
FOU, Alm.del - 2016-17 - Bilag 29: Præsentation fra Nordic Integrative Medicines (NIM) foretræde 8/12-16 om en integreret sundhedspolitik, herunder for forsvarets personel
1703588_0022.png
U.S. Air Force & Duke Integra;ve Medicine
Research Collabora;on
Gene4c Risk and Health Coaching for Type 2 Diabetes and
Coronary Heart Disease
• 
(U.S. Air Force funded) The purpose of this study is to
examine whether the use of gene;c test informa;on and/
or health coaching in pa;ent risk counseling for heart
disease and diabetes affects health behaviors and health
outcomes in ac;ve-duty Air Force, beneficiaries or
dependents and Air Force re;ree pa;ents. Par;cipants are
being recruited from the David Grant Medical Center at
Travis Air Force Base and the McClellan Outpa;ent Satellite
Clinic in California.
hjps://www.dukeintegra;vemedicine.org/research/
current-research-studies/
12/14/16 17:15
© Shelley Noble-Letort, PhD
director@nordicintegra;vemedicine.com
+45 2116 3939
22
FOU, Alm.del - 2016-17 - Bilag 29: Præsentation fra Nordic Integrative Medicines (NIM) foretræde 8/12-16 om en integreret sundhedspolitik, herunder for forsvarets personel
1703588_0023.png
12/14/16 16:43
© Shelley Noble-Letort, PhD
director@nordicintegra;vemedicine.com
+45 2116 3939
23
FOU, Alm.del - 2016-17 - Bilag 29: Præsentation fra Nordic Integrative Medicines (NIM) foretræde 8/12-16 om en integreret sundhedspolitik, herunder for forsvarets personel
1703588_0024.png
12/14/16 16:43
© Shelley Noble-Letort, PhD
director@nordicintegra;vemedicine.com
+45 2116 3939
24